Product Information
PHENTERMINE 30 MG CAPSULE is a generic product labeled by KVK-Tech Inc., priced at $0.1260 per EA under NDC 10702002801. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 21, 2008. Its Orange Book therapeutic-equivalence code is AA.
Strength
30 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702002801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040875FDA Approved
3/21/2008
TE Code
AA
On Market Since
8/7/2012
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 30 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1260 per EA |
|---|---|
| All-time high | $0.2543 (Feb 12, 2014) |
| All-time low | $0.0923 (Mar 18, 2026) |
| 52-week high | $0.1260 |
| 52-week low | $0.0923 |
| Median price | $0.1584 |
| Average price | $0.1603 |
| Largest weekly change | +58.1% (Mar 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
KVK-Tech Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phentermine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sympathomimetic Amine Anorectic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENTERMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 30 MG CAPSULE, manufactured by KVK-Tech Inc., is $0.1260 per EA (NDC 10702002801), effective Sep 30, 2026.
How has the price of PHENTERMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 30 MG CAPSULE has declined 42.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for PHENTERMINE 30 MG CAPSULE has ranged from a low of $0.0923 (Mar 18, 2026) to a high of $0.2543 (Feb 12, 2014), with a median of $0.1584 per EA.
Are there cheaper alternatives to PHENTERMINE 30 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PHENTERMINE 30 MG CAPSULE, is $0.1044 per EA — about 17% below PHENTERMINE 30 MG CAPSULE.
Who manufactures PHENTERMINE 30 MG CAPSULE?
PHENTERMINE 30 MG CAPSULE (NDC 10702002801) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.